NaturalShrimp to study fish health in RAS
A company considered to be a pioneer in recirculating aquaculture systems (RAS) for shrimp production could be moving closer to taking a dip into the freshwater fish market.
NaturalShrimp Inc., has announced it will be launching a study on fish health in RAS.
The short-term validation study looking into the effects of hyper-antioxidant technologies on oxidation and fish health will be undertaken at the at the Marineholmen RASLab, in Bergen Norway.
“The focus of the study will be specifically on freshwater salmon production and, if proven as effective as the pre-study data has indicated, the technologies could open the door for NaturalShrimp to enter various freshwater fish markets,” a press release from the company said.
The study will also test technologies that create antioxidant environments that reduce the redox reaction in fish gills and counteract fish susceptibility to the harmful effects of ammonia.
NaturalShrimp is funding the RASLab research through its market development partnership with Hydrenesis, Inc., which is the exclusive commercialization agent for technologies in the aquaculture market.
“These platform technologies could be a real breakthroughs for NaturalShrimp because they could prove to reduce mortality and increase growth rates for our existing shrimp production, but also enable us to enter the freshwater farming business with a significant differentiation,” said Gerald Easterling, president and chief executive officer of NaturalShrimp.
“New technological approaches to land-based farming and RAS technology are critical if the industry is to progress,” said Mark Powell, CEO of RASLab. “The Hydrenesis technology has the potential to offer a real breakthrough in managing water quality and fish health in fish grow-out systems – RASLab was built to undertake such tests and support the development of these technological innovations. We are delighted to be a part of this project.”